FDA WARNING: Pfizer’s RSV shot may lead to Guillain-Barre syndrome in older adults

(NaturalHealth365)  For every 100,000 people living in the United States, two have Guillain-Barre syndrome.  The syndrome is the top cause of the paralysis referred to as “acute flaccid.”  It is particularly interesting to note that the syndrome occurs at a rate of 1.5 per 100,000 people in the age cohort of 0 to 15 and 8.6 per 100,000 in the age cohort of 70 to 79, meaning vulnerable senior citizens are at risk.

Guillain-Barre syndrome is in the headlines after a startling revelation implicating the RSV shot’s causal relationship to the disability.  RSV, short for respiratory syncytial virus, has risen over the past year as the world has slowly emerged from pandemic lockdowns.

Does the Pfizer RSV shot cause Guillain-Barre syndrome?

In Pfizer’s clinical trial, 2 of the 20,000 participants developed Guillain-Barre syndrome.  However, this figure could significantly increase in the days, weeks, months, and years ahead.  There appears to be a causal relationship as opposed to a correlation between the RSV shot and the development of Guillain-Barre syndrome.

Even the FDA has come out of the woodwork to shine the spotlight on the potential risk of the Pfizer RSV shot, requesting that the Big Pharma giant perform a safety analysis on the alleged causal relationship between the shot and the syndrome.  Pfizer executives responded to the request and agreed to conduct the safety study.

Pfizer’s competitor, UK-based pharmaceutical company Glaxo Smith Klein (GSK), also reported similar adverse events during its RSV clinical trial.  However, the company’s public relations specialists indicated insufficient data to confirm a direct causal relationship.

Pfizer PR specialists insist they found no safety issues during trials, and its RSV shot was well-tolerated.  Translate the “corporate speak” of the companies’ press releases to get to the truth of the matter, and it becomes glaringly obvious that the syndrome is a legitimate risk.  However, it might take months, years, or decades for GSK or Pfizer representatives to admit that a causal relationship between RSV shots and the syndrome exists.

In the meantime, the FDA acknowledges senior citizens who take the RSV shot are more likely to develop this form of inflammatory neuropathy in which the immune system errantly goes on the offensive against the body’s nervous system, causing paralysis and/or weakness.  Though some elderly individuals can bounce back to normal after the shot and the subsequent development of Guillain-Barre syndrome, others may face lifelong consequences.

How to protect yourself against RSV

One way to raise awareness about the potential dangers of RSV shots is to evaluate the risks and benefits of different treatment methods.  While the RSV shot may appear to be the ‘only option’ for some people, other alternatives may offer greater advantages than an injection.

It’s important to explore all available options, including natural remedies that can boost the immune system.  Eating a healthy and balanced diet, exercising regularly, getting enough sleep, managing stress, staying hydrated, and practicing good hygiene are all important steps to support immune function.

In addition, avoiding an overreliance on medications can increase your chances of defending your body against harmful pathogens.  Remember, boosting immune function is an ongoing process that requires consistent effort and healthy lifestyle habits.

Sources for this article include:

Dailymail.co.uk
Emedicine.medscape.com
Thegatewaypundit.com
CDC.gov

The post FDA WARNING: Pfizer’s RSV shot may lead to Guillain-Barre syndrome in older adults appeared first on NaturalHealth365.

Visit Natural Health 365 Here /